HPV prophylactic vaccines

• P 05-01 • PREVALENCE AND GENOTYPING OF HPV IN A PORTUGUESE VACCINATED POPULATION > R. Rebelo Teresa • P 05-02 • PREVALENCE OF HPV INFECTION AND HYPOTHETICAL EFECT OF THE NONAVALENT VACCINE IN WESTERN HUESCA (SPAIN) > F. Francisco Javier Queipo. Gutierrez, • P 05-03 • ASSOCIATION BETWEEN PAP ABNORMALITIES AND HPV INFECTION IN PARTICIPANTS IN HPV VACCINE CLINICAL TRIALS > A. Amita Joshi • P 05-04 • IMPACT AND EFFECTIVENESS OF THE QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINE ON ORAL AND ANAL HPV INFECTIONS AND RECURRENT RESPIRATORY PAPILLOMATOSIS > R. Rosybel Drury • P 05-05 • A SYSTEMATIC LITERATURE REVIEW UPDATE OF THE IMPACT AND EFFECTIVENESS OF THE QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINE ON CERVICAL ABNORMALITIES > B. Barb Kuter • P 05-06 • Prevention of HPV-associated recurrence of CIN3: the experience of vaccination against HPV > O. Olga Trushina • P 05-07 • VERY LOW PREVALENCE OF VACCINE HUMAN PAPILLOMAVIRUS (HPV) AMONG VACCINATED SEXUALLY ACTIVE YOUNG WOMEN: A STUDY IN EASTERN FRANCE > C-H. Charles-Henri Bretagne